For the last two years, Dr. Michelle Perro has been in the trenches treating COVID-19 complications, not only from the infection but also from the jab, which is far more problematic and deadly. Perro went to Yale as an undergrad, and then to Mount Sinai Medical School. She completed her postgraduate residency training in pediatrics… Read More »
ThreatQ Platform and ThreatQ Investigations will be used by telecom conglomerate Comcast, parent of NBC Universal and SKY Group, to operationalise security intelligence across cybersecurity use cases London, UK. – May 17, 2022 – ThreatQuotient™, a leading security operations platform innovator, today announced that Comcast (NASDAQ:CMCSA) has selected the ThreatQ Platform and ThreatQ Investigations to… Read More »
Tübingen, Germany, May 11, 2022 Acousia Therapeutics GmbH will be presenting data on the company’s clinical stage, first-in-class lead candidate ACOU085 at the Hanson Wade 2nd Inner Ear Therapeutics Summit to be held in person in Boston (MA) from June 20–23, 2022. ACOU085 is a proprietary, first-in-class, small-molecule otoprotective drug candidate, which is currently being… Read More »
The initiative launched by Ethan and David Liddiard Group in collaboration with Blancco aims to improve digital inclusion by providing access to devices for Australia’s Indigenous community Australia – May, 10 2022 — Blancco Australasia PTY LTD, the industry standard in data erasure and mobile device diagnostics, today announced it has partnered with Ethan Indigenous… Read More »